abagovomab MeSH Supplementary Concept Data 2025

Details
Concepts

MeSH Supplementary: abagovomab
Unique ID: C518318
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C518318
Entry Term(s): ACA-125; ACA125; MEN-2234
Pharm Action: Antineoplastic Agents, Immunological
Registry Numbers: 3YK0326U7X
Previous Indexing: *Antibodies, Anti-Idiotypic (2007-2009)
Heading Mapped to: *Antibodies, Monoclonal, Murine-Derived
Frequency: 13
Note: used for treatment of recurrent ovarian cancer
Source: Ann Oncol 2006 Oct;17(10):1568-77
Date of Entry: 2007/03/26
Revision Date: 2019/10/30

abagovomab Preferred

ACA-125 Narrower

MEN-2234 Narrower

page delivered in 0.005s